Zobrazeno 1 - 10
of 218
pro vyhledávání: '"J-F. Morere"'
Autor:
François Eisinger, H. Naman, Chantal Touboul, Christine Lhomel, Jérôme Viguier, Hélène Simon, J-F. Morere, Gérard Ganem
Publikováno v:
Cancer Research. 79:P1-11
Background Comprehensive cancer care uses complementary approaches alongside specific anticancer therapy. Using a dedicated questionnaire, the Calista 2 national survey sought to assess the importance of supportive care and activities among breast ca
Autor:
Christine Lhomel, L. Brignoli-Guibaudet, Jérôme Viguier, Laurent Greillier, Alexis B. Cortot, S. Couraud, J-F. Morere, François Eisinger, J.-Y. Blay
Publikováno v:
Cancer Research. 78:P6-08
Background The EDIFICE surveys have been conducted since 2005 to provide a better understanding of the participation of the French population in cancer screening programs. The breast cancer (BC) screening program is nowadays widely implemented throug
Autor:
François Eisinger, Xavier Pivot, Chantal Touboul, J.-Y. Blay, Jérôme Viguier, Christine Lhomel, J-F. Morere
Publikováno v:
Cancer Research. 76:P6-09
Background The EDIFICE surveys have been conducted every three years since 2005. The aim of the surveys is to provide a better understanding of the participation of the French population in cancer screening programs. The breast cancer screening progr
Autor:
X. Pivot, Philippe Saiag, Jérôme Viguier, Christine Lhomel, Florent Grange, Laurent Mortier, Caroline Robert, J-F. Morere, François Eisinger, Bruno Sassolas
Publikováno v:
Journal of the European Academy of Dermatology and Venereology. 29:35-38
Objectives The incidence of skin cancers, melanoma in particular, is increasing rapidly. Consequently, specific recommendations for sun-protection measures now exist. This survey set out to assess the compliance of the general population with these g
Autor:
T. de La Motte Rouge, M. Roupret, J-F. Morere, Jérôme Viguier, S. Couraud, Chantal Touboul, François Eisinger, Christine Lhomel, Laurent Greillier
Publikováno v:
Annals of Oncology. 30:v426
Background The mean age at diagnosis of cervical cancer (CC) is 51 yrs old. Recommendations on cervical cancer screening has recently been implemented as a nationally organized program in France. Since 2018, women aged 25-65 yrs are now invited for a
Autor:
T. De La Motte Rouge, François Eisinger, Laurent Greillier, Chantal Touboul, Jérôme Viguier, M. Roupret, Christine Lhomel, J-F. Morere, S. Couraud
Publikováno v:
Journal of Thoracic Oncology. 14:S513
Autor:
S. Couraud, T. De La Motte Rouge, François Eisinger, M. Roupret, Laurent Greillier, J-F. Morere, Chantal Touboul, Jérôme Viguier, Christine Lhomel
Publikováno v:
European Urology Supplements. 18:e316
Publikováno v:
Cancer Research. 73:P1-09
BACKGROUND: We decided to evaluate the effect of patient navigation in an area (Seine-Saint-Denis, SSD) with an estimated population of 1.4 billion, which is among the poorest in France. Median household income is 68% lower than in Paris (+68%), a ga
Autor:
Nicolas Janus, Joseph Gligorov, J.-B. Rey, Florian Scotté, Gilbert Deray, R Dorent, François Goldwasser, J-C Thery, J-P Spano, P. Beuzeboc, Catherine Daniel, J-F. Morere, Michel Azizi, Christelle Jouannaud, Olivier Mir, I.L. Ray-Coquard, Vincent Launay-Vacher, Stéphane Oudard
Publikováno v:
Cancer Research. 73:P3-15
Background: Anti-VEGF drugs (AVD) are widely used in cancer patients (pts). Hypertension (HTN) and proteinuria (Pu) are class-side-effects of AVD, related to the inhibition of the VEGF pathway. The MARS study has been conducted to assess the renovasc
Autor:
Gilbert Deray, François Goldwasser, Christelle Jouannaud, J.-B. Rey, Stéphane Oudard, Joseph Gligorov, R Dorent, Catherine Daniel, J-C Thery, J-P Spano, I.L. Ray-Coquard, Vincent Launay-Vacher, Michel Azizi, Olivier Mir, Nicolas Janus, J-F. Morere, P. Beuzeboc
Publikováno v:
Cancer Research. 72:P5-17
Background: Hypertension (HTN) and proteinuria (Pu) are class-side-effects of anti-VEGF drugs (AVD), related to the inhibition of the VEGF pathway. The MARS study has been conducted to assess the renovascular tolerance of these drugs in the clinical